You signed in with another tab or window. Reload to refresh your session.You signed out in another tab or window. Reload to refresh your session.You switched accounts on another tab or window. Reload to refresh your session.Dismiss alert
Intersect ENT (the "Intersectent" stub) was a Menlo Park, California medical-device company that developed steroid-releasing dissolvable sinus implants — the PROPEL and PROPEL mini families and the SINUVA implant — to improve outcomes for chronic sinusitis and ear, nose and throat surgery.
Intersect ENT was a medical device company based in Menlo Park, California that developed drug-eluting, bioresorbable sinus implants for patients with chronic rhinosinusitis. Its PROPEL family of steroid-eluting implants maintains sinus patency and delivers localized mometasone furoate to the sinus mucosa following endoscopic sinus surgery, while…